Olverembatinib (HQP1351), a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI, has been approved in ...

In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in Working Capital; Cash Runway Extending into Q4, Well Beyond Target Date for ...

Home Minister Amit Shah in the Rajya Sabha on Tuesday launched a scathing attack on the Congress party's management of the ...

Speaking on recent demand by Hindu groups to remove Aurangzeb's Grave, RSS General Secretary Dattatreya Hosabale said that ...